Central sleep apnea after acute coronary syndrome and association with ticagrelor use

• Published in: Sleep medicine Vol. 80; pp. 39 - 45
• Main Authors: Meurin, Ph, Ben Driss, A., Defrance, C., Dumaine, R., Weber, H., Renaud, N., Bonnevie, L., Mouram, S., Tabet, J.Y.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2021
• Subjects: Acute coronary syndrome; Acute Coronary Syndrome - complications; Acute Coronary Syndrome - drug therapy; Aged; Antiplatelet drug; Central sleep apnea; Cheyne-Stokes respiration; Female; Humans; Male; Middle Aged; Sleep Apnea, Central - chemically induced; Stroke Volume; Ticagrelor; Ticagrelor - adverse effects; Ventricular Function, Left; Cheyne-Stokes respiration; Central sleep apnea; Ticagrelor; Acute coronary syndrome; Antiplatelet drug

By modifying the apneic threshold, the antiplatelet agent ticagrelor could promote central sleep apnea hypopnea syndrome (CSAHS). We aimed to assess the association between CSAHS and ticagrelor administration. Patients were prospectively included within 1 year after acute coronary syndrome (ACS), if...